Nuzenio

Phase Iib Clinical

Phase Iib Clinical news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 10:38:46 GMT BioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMT Migraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise ReportsStreetwise Reports · Thu, 06 Aug 2026 09:41:48 GMT 4DMT reports new phase 2b gene therapy data for wet AMD - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Wed, 05 Aug 2026 18:49:23 GMT SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMT NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:48:44 GMT SciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMT Tourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMT

Timeline

Mon, 10 Aug 2026 10:38:46 GMTVeru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress - The Manila Times

Fri, 07 Aug 2026 10:14:16 GMTBioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials Arena

Thu, 06 Aug 2026 09:41:48 GMTMigraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise Reports

Wed, 05 Aug 2026 18:49:23 GMT4DMT reports new phase 2b gene therapy data for wet AMD - Glance by Eyes On Eyecare

Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan

Wed, 05 Aug 2026 12:48:44 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo Finance

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Clinical Trials Arena9 live mentions Phase IIb6 live mentions Phase4 live mentions Phase IIb SCI4 live mentions Eyes On Eyecare3 live mentions Tourette3 live mentions Veru Reports Fiscal2 live mentions Third Quarter Financial2 live mentions Results2 live mentions PLATEAU Clinical Trial2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phase Iib Clinical.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.